Motif Becomes a Key Player in Organigram’s Expansion with CA$90 Million Acquisition

In a significant move within the Canadian cannabis industry, Organigram, a leading licensed producer of cannabis, has announced its acquisition of 100% of the issued and outstanding shares of Motif Labs for an upfront consideration of CA$90 million. The deal includes CA$50 million in cash and CA$40 million worth of Organigram common shares. Additionally, Motif shareholders will be entitled to receive a contingent consideration of CA$10 million payable in Organigram shares.

The acquisition solidifies Organigram’s position as Canada’s largest cannabis company by market share, further expanding its portfolio in key product categories. With Motif’s innovative contributions in the vape and infused pre-roll categories, Organigram is well-positioned to meet growing consumer demand and stay ahead of market trends in Canada’s competitive cannabis landscape.

Organigram CEO: A Strategic Vision for the Future

Beena Goldenberg, CEO of Organigram, expressed enthusiasm about the acquisition, highlighting the strategic advantages that Motif brings to the table. “The highly complementary acquisition of Motif establishes Organigram as Canada’s largest cannabis company by market share and accelerates our vision to be a leading cannabis company across all major categories,” Goldenberg said.

She emphasized the company’s commitment to remaining consumer-centric, aiming to lead not only in Canada—the world’s largest federally legal recreational market—but also in emerging global markets as regulatory changes open new opportunities. “Winning in Canada, supported by leading brands, innovation, and best-in-class operations, provides the platform to unlock global opportunities,” she added.

Motif’s Market Leadership and Expertise in Vape and Pre-Roll Categories

Motif Labs, founded in 2017, has established itself as a leader in the vape and infused pre-roll segments of the cannabis market. The company is known for its efficient manufacturing processes and its ability to rapidly design, develop, and launch cannabis products that resonate with consumers.

Motif’s product portfolio includes its popular BOXHOT brand, which has garnered significant market attention. The company has consistently demonstrated its capability to scale operations and produce products that meet the evolving demands of cannabis users. In addition to its brand portfolio, Motif operates a wholesale division and offers end-to-end services for external cannabis brands.

“We are proud to say that today, not only is Motif one of Canada’s largest and most efficient extractors, but we have also commercialized a portfolio of leading, widely distributed brands,” said Mario Naric, CEO and Founder of Motif. “This acquisition marks a landmark transaction in our industry, and we are thrilled to be joining forces with Organigram to create Canada’s undisputed leader in the cannabis space.”

Motif’s #1 position in the vape category and #3 in infused pre-rolls represent a significant milestone in their success, underlining their market strength and reputation for innovation. As part of the acquisition, Motif will continue to operate from its headquarters in Aylmer, Ontario, with future support from a new large distribution warehouse set to open in London, Ontario.

Strategic Synergies: Combining Strengths for Market Expansion

Organigram’s decision to acquire Motif Labs is seen as a strategic move to solidify its position in the Canadian cannabis market. With Motif’s expertise in cannabis extracts and Organigram’s established presence in other cannabis sectors, the merger will create a powerhouse with a broad range of products and capabilities across the cannabis space.

“Motif’s proven track record in product innovation and scaling its operations fits seamlessly with Organigram’s growth strategy,” said Paolo De Luca, Chief Strategy Officer at Organigram. “This deal is about a leading public cannabis company joining forces with Canada’s top private licensed producer. Together, we have the competitive advantage to continue our growth trajectory both in Canada and internationally.”

Organigram’s previous experience in executing mergers and acquisitions (M&A) in the Canadian cannabis market has been highly successful, allowing the company to expand its footprint and increase market share. This acquisition marks another step in their aggressive growth strategy, one that will see them leverage Motif’s established infrastructure and brand power.

The Road Ahead: Creating Canada’s Undisputed Cannabis Leader

With this acquisition, Organigram aims to further consolidate its leadership position in the Canadian cannabis market. The combination of Motif’s innovative products and Organigram’s operational expertise presents new opportunities for both companies. As cannabis consumption continues to grow, especially in vape and infused pre-roll categories, the combined entity is set to capture an even larger market share and drive further innovation.

The deal also marks a key moment in the broader cannabis industry, highlighting the ongoing consolidation as companies seek to build scale and diversify their offerings. As Canada’s cannabis market matures and new regulatory developments unfold, this acquisition places Organigram in a strong position to capitalize on both domestic and international opportunities.

For Motif, joining Organigram means greater resources, expanded distribution, and the ability to reach more consumers across Canada and beyond. As cannabis regulations evolve globally, the combined company will have the infrastructure and product variety needed to adapt to new market demands and continue its growth trajectory.

A New Era for Organigram and Motif

The acquisition of Motif Labs by Organigram represents a strategic milestone in the Canadian cannabis industry, offering both companies significant advantages. With Motif’s leadership in the vape and infused pre-roll categories and Organigram’s robust market presence and M&A expertise, the merger promises to redefine the competitive landscape in Canada’s cannabis market.

As the cannabis industry continues to evolve, Organigram’s acquisition of Motif is a signal of the growing importance of innovation, operational efficiency, and consumer-centric approaches in shaping the future of cannabis in Canada and beyond. This partnership sets the stage for a new era of growth, product innovation, and market leadership in the global cannabis space.